FGFR2 and colorectal carcinoma: FGFR2 has been reported to promote PD-L1 expression in a xenograft mouse model and induce PD-L1 expression via the JAK/STAT3 signaling pathway, causing apoptosis of T lymphocytes in CRC [37].